These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11102619)

  • 21. The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study.
    Verbruggen MB; van Diest PJ; Baak JP; Broeckaert MA; Kenemans P; Verheijen RH
    Int J Gynecol Pathol; 2009 Jan; 28(1):35-40. PubMed ID: 19047910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
    Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
    Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Karlsson M; Seidal T
    Int J Oncol; 2001 Dec; 19(6):1295-302. PubMed ID: 11713603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRCA1 mutation site may be linked with nuclear DNA ploidy in BRCA1-mutated ovarian carcinomas.
    Aghmesheh M; Saxena A; Niknam F
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):135-41. PubMed ID: 25428229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
    Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
    Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cigarette smoking on epithelial ovarian cancer survival.
    Ioffe YJ; Elmore RG; Karlan BY; Li AJ
    J Reprod Med; 2010; 55(7-8):346-50. PubMed ID: 20795350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.
    Sadlecki P; Walentowicz P; Bodnar M; Marszalek A; Grabiec M; Walentowicz-Sadlecka M
    Tumour Biol; 2017 May; 39(5):1010428317706230. PubMed ID: 28488545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in gene expression during progression of ovarian carcinoma.
    Tapper J; Kettunen E; El-Rifai W; Seppälä M; Andersson LC; Knuutila S
    Cancer Genet Cytogenet; 2001 Jul; 128(1):1-6. PubMed ID: 11454421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral Sertoli cell adenoma in gonads, associated with serous cystadenoma.
    Fernandez-Vega I; Santos-Juanes J; García-Pravia C
    Pol J Pathol; 2014 Jun; 65(2):154-6. PubMed ID: 25119177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
    Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow and image cytometric DNA ploidy, including 5c exceeding cells, of serous borderline malignant ovarian tumors. Correlation with clinicopathologic characteristics.
    Flezar MS; But I; Kavalar R; Us-Krasovec M
    Anal Quant Cytol Histol; 2003 Jun; 25(3):139-45. PubMed ID: 12882085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
    Usami T; Kato K; Taniguchi T; Abe A; Nomura H; Yamamoto A; Matoda M; Okamoto S; Kondo E; Omatsu K; Kawamata Y; Takeshima N
    Int J Gynecol Cancer; 2014 Jul; 24(6):991-6. PubMed ID: 24905612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical value of DNA ploidy in ovarian cancer].
    Obrebowska A; Spaczyński M
    Ginekol Pol; 1997 Oct; 68(10):478-82. PubMed ID: 9780508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidylate synthase activity as a prognostic factor in ovarian cancer.
    Suzuki M; Ohwada M; Tamada T; Tsuru S
    Oncology; 1994; 51(4):334-8. PubMed ID: 8208516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival and DNA ploidy in advanced epithelial ovarian cancer.
    Resnik E; Trujillo YP; Taxy JB
    J Surg Oncol; 1997 Apr; 64(4):299-303. PubMed ID: 9142186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
    Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of DNA quantification by flow cytometry in ovarian tumors.
    Kim YT; Zhao M; Kim SH; Lee CS; Kim JH; Kim JW
    Int J Gynaecol Obstet; 2005 Mar; 88(3):286-91. PubMed ID: 15733883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.